Literature DB >> 16000846

Proposal for the histological classification of parathyroid carcinoma.

Kaori Kameyama1, Hiroshi Takami.   

Abstract

Although the criteria of Schantz and Castleman are widely used in the diagnosis of parathyroid carcinoma, many tumors diagnosed as carcinoma subsequently do not recur. In addition, although Bondeson's criteria are used to grade parathyroid carcinoma, instances of patient mortality have been documented even in cases where the histological features did not conform to the criteria for high grade. Considering our experience, we believe that the subclassification of parathyroid carcinomas defining tumors limited local infiltration as low-grade and those with widespread infiltration as high-grade may be useful.

Entities:  

Mesh:

Year:  2005        PMID: 16000846     DOI: 10.1385/ep:16:1:049

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  13 in total

1.  Parathyroid carcinoma in a patient receiving long-term hemodialysis.

Authors:  H Takami; K Kameyama; I Nagakubo
Journal:  Surgery       Date:  1999-02       Impact factor: 3.982

2.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

Review 3.  Parathyroid carcinoma: a review of 62 patients.

Authors:  E Shane; J P Bilezikian
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

4.  Parathyroid carcinomas: can clinical outcomes for parathyroid carcinomas be determined by histologic evaluation alone?

Authors:  Kaori Kameyama; Ronald A DeLellis; Ricardo V Lloyd; Kennichi Kakudo; Hiroshi E Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

5.  Histopathological variables and DNA cytometry in parathyroid carcinoma.

Authors:  L Bondeson; K Sandelin; L Grimelius
Journal:  Am J Surg Pathol       Date:  1993-08       Impact factor: 6.394

6.  Functional parathyroid carcinoma. Cytology, histology, and ultrastructure of a case.

Authors:  S de la Garza; E Flores de la Garza; F Hernández Batres
Journal:  Diagn Cytopathol       Date:  1985 Jul-Sep       Impact factor: 1.582

7.  Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas.

Authors:  Ricardo V. Lloyd; J. Aidan Carney; Jorge A. Ferreiro; Long Jin; Geoffrey B. Thompson; Jon A. Van Heerden; Clive S. Grant; Peter C. Wollan
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

8.  Carcinoma of the parathyroid gland. A light and electronmicroscopic study.

Authors:  S Holck; N T Pedersen
Journal:  Acta Pathol Microbiol Scand A       Date:  1981-07

9.  Prognostic factors in parathyroid cancer: a review of 95 cases.

Authors:  K Sandelin; G Auer; L Bondeson; L Grimelius; L O Farnebo
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

10.  Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.

Authors:  V L Cryns; A Thor; H J Xu; S X Hu; M E Wierman; A L Vickery; W F Benedict; A Arnold
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

View more
  4 in total

1.  Hungry bone syndrome after parathyroidectomy of a minimally invasive parathyroid carcinoma.

Authors:  Kwang-Min Kim; Joon-Beom Park; Keum-Seok Bae; Seong-Joon Kang
Journal:  J Korean Surg Soc       Date:  2011-11-01

2.  Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.

Authors:  Gaurav Agarwal; Kaushal K Prasad; Dilip K Kar; Narendra Krishnani; Rakesh Pandey; Saroj K Mishra
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 3.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

4.  Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.

Authors:  Peter P Truran; Sarah J Johnson; Richard D Bliss; Thomas W J Lennard; Sebastian R Aspinall
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.